Javascript must be enabled to continue!
Specific expression of hepatocyte nuclear factor‐1β in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis
View through CrossRef
Ascitic cytological diagnosis is critical, but ovarian adenocarcinoma cells and reactive mesothelial cells can be difficult to distinguish because they usually have atypical cell nuclei and increased nuclear/cytoplasmic ratios. Previous studies using DNA microarrays have demonstrated that hepatocyte nuclear factor‐1β (HNF‐1β) is expressed specifically in clear cell adenocarcinoma (CCC). Thus, in the present study, we investigated the usefulness of HNF‐1β as an immunocytochemical diagnostic marker of CCC in ascitic specimens. We first confirmed that HNF‐1β expression levels were significantly higher in CCC than in non‐CCC (i.e. serous adenocarcinoma, mucinous adenocarcinoma and endometrioid adenocarcinoma) in 55 surgical specimens at both the mRNA (P < 0.05) and protein (P < 0.05) levels by real‐time polymerase chain reaction and immunohistochemistry, respectively. Immunocytochemistry of 60 cytological specimens showed significant positivity in CCC cases whereas all non‐CCC cells, except for three endometrioid adenocaricnoma cases, and mesothelial cells in the background stained negatively for anti‐HNF‐1β antibody (P < 0.05). The sensitivity and specificity were calculated to be 0.955 and 0.921, respectively. Immmunostaining patterns of HNF‐1β on cytological specimens were similar to those observed on histopathological ovarian specimens from the same patients. Double immunohistochemical staining using anti‐HNF‐1β antibody and HBME‐1, a mesothelium‐specific monoclonal antibody, confirmed that anti‐HNF‐1β antibody distinguished CCC cells and mesothelial cells. In conclusion, our findings indicate the specific expression of HNF‐1β in ovarian CCC and possible clinical applications of HNF‐1β immunocytochemical staining for the differential cytopathological diagnosis of CCC from non‐CCC, as well as from mesothelial cells using cytological specimens from ovarian carcinoma patients. (Cancer Sci 2007; 98: 387–391)
Title: Specific expression of hepatocyte nuclear factor‐1β in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis
Description:
Ascitic cytological diagnosis is critical, but ovarian adenocarcinoma cells and reactive mesothelial cells can be difficult to distinguish because they usually have atypical cell nuclei and increased nuclear/cytoplasmic ratios.
Previous studies using DNA microarrays have demonstrated that hepatocyte nuclear factor‐1β (HNF‐1β) is expressed specifically in clear cell adenocarcinoma (CCC).
Thus, in the present study, we investigated the usefulness of HNF‐1β as an immunocytochemical diagnostic marker of CCC in ascitic specimens.
We first confirmed that HNF‐1β expression levels were significantly higher in CCC than in non‐CCC (i.
e.
serous adenocarcinoma, mucinous adenocarcinoma and endometrioid adenocarcinoma) in 55 surgical specimens at both the mRNA (P < 0.
05) and protein (P < 0.
05) levels by real‐time polymerase chain reaction and immunohistochemistry, respectively.
Immunocytochemistry of 60 cytological specimens showed significant positivity in CCC cases whereas all non‐CCC cells, except for three endometrioid adenocaricnoma cases, and mesothelial cells in the background stained negatively for anti‐HNF‐1β antibody (P < 0.
05).
The sensitivity and specificity were calculated to be 0.
955 and 0.
921, respectively.
Immmunostaining patterns of HNF‐1β on cytological specimens were similar to those observed on histopathological ovarian specimens from the same patients.
Double immunohistochemical staining using anti‐HNF‐1β antibody and HBME‐1, a mesothelium‐specific monoclonal antibody, confirmed that anti‐HNF‐1β antibody distinguished CCC cells and mesothelial cells.
In conclusion, our findings indicate the specific expression of HNF‐1β in ovarian CCC and possible clinical applications of HNF‐1β immunocytochemical staining for the differential cytopathological diagnosis of CCC from non‐CCC, as well as from mesothelial cells using cytological specimens from ovarian carcinoma patients.
(Cancer Sci 2007; 98: 387–391).
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
P-677 fasting-mimicking diet delays ovarian aging by modulating immune cells and enhancing glycocholic acid levels
P-677 fasting-mimicking diet delays ovarian aging by modulating immune cells and enhancing glycocholic acid levels
Abstract
Study question
Does fasting-mimicking diet (FMD) alleviate ovarian aging in mice, and what roles do gut and serum metab...
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
Abstract
Study question
Could ovarian vascularity indices, measured by 3-dimensional (3D) vaginal power Doppler, predict the num...
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Abstract
Background
2020 World Health Organization Classification of Female Genital Tumors removed ovarian seromucinous carcinoma as a distinct enti...
Abstract 875: PAX8 protein detection in serum of patients with serous ovarian cancer
Abstract 875: PAX8 protein detection in serum of patients with serous ovarian cancer
Abstract
Introduction: The paired-box (PAX) genes encode a family of transcription factors (TFs) with critical roles in the formation of tissues and organs during em...
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract
Epithelial ovarian cancer (EOC) accounts for 5% of all cancer deaths and is the fifth leading cause of cancer death in women in the United States. While the...
Abstract A65: Snail, a potent inducer of global DNA methylation in ovarian cancer
Abstract A65: Snail, a potent inducer of global DNA methylation in ovarian cancer
Abstract
Snail plays a critical role in the epithelial to mesenchymal transition (EMT). To investigate the role of Snail in this event, we established inducible Snai...

